Review of Coronary Late Breaking Trials From the TCT Connect 2020 Virtual Meeting.
作者信息
Medranda Giorgio A, Case Brian C, Wermers Jason P, Morrison Natalie, Yerasi Charan, Forrestal Brian, Chezar-Azerrad Chava, Waksman Ron
机构信息
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.
Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States of America.
出版信息
Cardiovasc Revasc Med. 2021 Jul;28:65-70. doi: 10.1016/j.carrev.2020.12.036. Epub 2021 Jan 4.
Abstract
摘要
相似文献
1
Review of Coronary Late Breaking Trials From the TCT Connect 2020 Virtual Meeting.2020年经导管心血管治疗（TCT）连线虚拟会议冠状动脉最新试验综述
Cardiovasc Revasc Med. 2021 Jul;28:65-70. doi: 10.1016/j.carrev.2020.12.036. Epub 2021 Jan 4.
2
Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).外周动脉疾病患者冠状动脉植入药物洗脱支架后的血小板反应性及临床结局：来自ADAPT-DES研究（药物洗脱支架双重抗血小板治疗评估）的分析
Circ Cardiovasc Interv. 2017 Mar;10(3). doi: 10.1161/CIRCINTERVENTIONS.116.004904.
3
Stent Thrombosis in Drug-Eluting or Bare-Metal Stents in Patients Receiving Dual Antiplatelet Therapy.双联抗血小板治疗患者的药物洗脱支架或裸金属支架内血栓形成。
JACC Cardiovasc Interv. 2015 Oct;8(12):1552-62. doi: 10.1016/j.jcin.2015.05.026.
4
Drug-eluting stent use with abbreviated dual antiplatelet therapy after percutaneous coronary intervention for liver transplantation evaluation.肝移植评估经皮冠状动脉介入治疗后使用药物洗脱支架与简化双联抗血小板治疗。
Liver Transpl. 2023 Apr 1;29(4):459-462. doi: 10.1097/LVT.0000000000000090. Epub 2023 Feb 7.
5
Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.EVOLVE 短程 DAPT 研究的主要结果：生物可吸收聚合物涂层依维莫司洗脱支架治疗高出血风险患者的 3 个月双联抗血小板治疗评估。
Circ Cardiovasc Interv. 2021 Mar;14(3):e010144. doi: 10.1161/CIRCINTERVENTIONS.120.010144. Epub 2021 Mar 1.
6
Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).支架置入术后联合西洛他唑与氯吡格雷双倍剂量治疗：HOST-ASSURE 随机试验（优化药物洗脱支架治疗策略以确保安全性和有效性及抗血小板方案的冠状动脉狭窄的协调性研究）。
JACC Cardiovasc Interv. 2013 Sep;6(9):932-42. doi: 10.1016/j.jcin.2013.04.022.
7
Drug-Eluting Versus Bare-Metal Stents in Older Patients: A Meta-Analysis of Randomized Controlled Trials.老年患者中药物洗脱支架与裸金属支架的比较：随机对照试验的荟萃分析
Cardiovasc Revasc Med. 2019 Sep;20(9):744-751. doi: 10.1016/j.carrev.2018.11.005. Epub 2018 Nov 7.
8
Clinical outcomes of patients treated using very short duration dual antiplatelet therapy after implantation of biodegradable-polymer drug-eluting stents: rationale and design of a prospective multicenter REIWA registry.经生物可降解聚合物药物洗脱支架置入术后采用极短疗程双联抗血小板治疗患者的临床结局：前瞻性多中心 REIWA 注册研究的原理和设计。
Cardiovasc Interv Ther. 2020 Oct;35(4):398-404. doi: 10.1007/s12928-020-00694-y. Epub 2020 Aug 10.
9
Sex Differences in the Clinical Impact of High Platelet Reactivity After Percutaneous Coronary Intervention With Drug-Eluting Stents: Results From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).药物洗脱支架经皮冠状动脉介入治疗后高血小板反应性临床影响的性别差异：ADAPT-DES研究（药物洗脱支架双重抗血小板治疗评估）结果
Circ Cardiovasc Interv. 2017 Feb;10(2). doi: 10.1161/CIRCINTERVENTIONS.116.003577.
10
Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.在不受限制的经皮冠状动脉介入治疗人群中使用双联抗血小板治疗评分预测缺血和出血事件。
Circ Cardiovasc Interv. 2018 Oct;11(10):e006853. doi: 10.1161/CIRCINTERVENTIONS.118.006853.
本文引用的文献
1
Effect of Prehospital Crushed Prasugrel Tablets in Patients With ST-Segment-Elevation Myocardial Infarction Planned for Primary Percutaneous Coronary Intervention: The Randomized COMPARE CRUSH Trial.拟行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者院前碾碎普拉格雷片的效果：随机 COMPARE CRUSH 试验。
Circulation. 2020 Dec 15;142(24):2316-2328. doi: 10.1161/CIRCULATIONAHA.120.051532. Epub 2020 Oct 14.
2
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease.血管内碎石术治疗严重钙化冠状动脉疾病。
J Am Coll Cardiol. 2020 Dec 1;76(22):2635-2646. doi: 10.1016/j.jacc.2020.09.603. Epub 2020 Oct 15.
3
Percutaneous Coronary Intervention for Vulnerable Coronary Atherosclerotic Plaque.经皮冠状动脉介入治疗易损冠状动脉粥样硬化斑块
J Am Coll Cardiol. 2020 Nov 17;76(20):2289-2301. doi: 10.1016/j.jacc.2020.09.547. Epub 2020 Oct 15.
4
Randomized evaluation of ticagrelor monotherapy after 3-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with new-generation sirolimus-eluting stents: TICO trial rationale and design.替卡格雷单药治疗在新一代西罗莫司洗脱支架治疗急性冠脉综合征患者 3 个月双联抗血小板治疗后的随机评估：TICO 试验的原理和设计。
Am Heart J. 2019 Jun;212:45-52. doi: 10.1016/j.ahj.2019.02.015. Epub 2019 Mar 7.
Zotero 插件